Patents by Inventor Patricia DePue

Patricia DePue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5773414
    Abstract: Novel antagonists of endothelin are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in treating elevated levels of endothelin, acute and chronic renal failure, hypertension, myocardial infarction, metabolic, endocrinological, neurological disorders, congestive heart failure, endotoxic shock, subarachnoid hemorrhage, arrhythmias, asthma, preeclampsia, Raynaud's disease, percutaneous transluminal coronary angioplasty or restenosis, angina, cancer, pulmonary hypertension, ischemic disease, gastric mucosal damage, ischemic bowel disease, and diabetes.
    Type: Grant
    Filed: March 7, 1997
    Date of Patent: June 30, 1998
    Assignee: Warner-Lambert Company
    Inventors: Wayne Livingston Cody, Patricia DePue, Annette Marian Doherty, John Xiaoqiang He, Michael Douglas Taylor
  • Patent number: 5641752
    Abstract: Novel antagonists of endothelin are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in treating elevated levels of endothelin, acute and chronic renal failure, hypertension, myocardial infarction, metabolic, endocrinological, neurological disorders, congestive heart failure, endotoxic shock, subarachnoid hemorrhage, arrhythmias, asthma, preeclampsia, Raynaud's disease, percutaneous transluminal coronary angioplasty or restenosis, angina, cancer, pulmonary hypertension, ischemic disease, gastric mucosal damage, ischemic bowel disease, and diabetes.
    Type: Grant
    Filed: September 30, 1994
    Date of Patent: June 24, 1997
    Assignee: Warner-Lambert Company
    Inventors: Wayne Livingston Cody, Patricia DePue, Annette Marian Doherty, John Xiaoqiang He, Michael Douglas Taylor
  • Patent number: 5382569
    Abstract: Novel antagonists of endothelin are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in treating elevated levels of endothelin, acute and chronic renal failure, hypertension, myocardial infarction, metabolic, endocrinological, neurological disorders, congestive heart failure, endotoxic shock, subarachnoid hemorrhage, arrhythmias, asthma, preeclampsia, Raynaud's disease, percutaneous transluminal coronary angioplasty or restenosis, angina, cancer, pulmonary hypertension, ischemic disease, gastric mucosal damage, ischemic bowel disease, and diabetes.
    Type: Grant
    Filed: December 21, 1992
    Date of Patent: January 17, 1995
    Assignee: Warner-Lambert Company
    Inventors: Wayne L. Cody, Patricia DePue, Annette M. Doherty, John X. He, Michael D. Taylor